Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
11.21
-0.14 (-1.23%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 609 employees as of September 30, 2024. The number of employees increased by 84 or 16.00% compared to the previous year.
Employees
609
Change (1Y)
84
Growth (1Y)
16.00%
Revenue / Employee
$4,105
Profits / Employee
-$1,050,433
Market Cap
1.42B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
ARWR News
- 3 days ago - Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer - Business Wire
- 14 days ago - Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Arrowhead Pharmaceuticals Is Finally Arriving - Seeking Alpha
- 5 weeks ago - Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy - Business Wire
- 6 weeks ago - Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases - Business Wire
- 7 weeks ago - Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS) - Business Wire
- 7 weeks ago - Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity - Business Wire
- 2 months ago - Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions - Seeking Alpha